
The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …
I’ve often said that however bad one’s research, it’s possible to get it published somewhere. I have been thinking about …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

